<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Hyperhidrosis — One‑Page Clinical Algorithm & Quick Reference</title>
  <meta name="description" content="Clean, modern one-page reference algorithm and quick guide for assessing and managing hyperhidrosis in primary care." />
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700;800&display=swap" rel="stylesheet">
  <style>
    :root{
      --bg: #0b0d12;
      --panel: #121520;
      --panel-2: #0f1320;
      --text: #e9edf3;
      --muted: #aeb6c7;
      --brand: #5aa5ff;
      --brand-2: #7dd3fc;
      --ok:#22c55e;--warn:#f59e0b;--err:#ef4444;
      --shadow: 0 10px 30px rgba(0,0,0,.35), 0 1px 0 rgba(255,255,255,.02) inset;
      --radius-xl: 22px; --radius-lg: 16px; --radius: 12px;
      --maxw: 1200px;
    }
    @media (prefers-color-scheme: light){
      :root{ --bg:#f6f7fb; --panel:#ffffff; --panel-2:#f2f5fb; --text:#0b1220; --muted:#49566a; --brand:#2563eb; --brand-2:#06b6d4; --shadow:0 8px 22px rgba(2,6,23,.08), 0 1px 0 rgba(2,6,23,.04) inset; }
    }
    *{box-sizing:border-box}
    html,body{margin:0; padding:0; background:var(--bg); color:var(--text); font-family:Inter,system-ui,Segoe UI,Roboto,Helvetica,Arial,sans-serif; line-height:1.5;}
    a{color:var(--brand); text-decoration:none}
    a:hover{text-decoration:underline}
    .container{max-width:var(--maxw); margin:0 auto; padding:24px;}

    /* Header */
    header.hero{position:relative; overflow:hidden; border-radius:var(--radius-xl); background: radial-gradient(1200px 500px at 20% -10%, rgba(90,165,255,.2), transparent 60%), linear-gradient(180deg, var(--panel), var(--panel-2)); box-shadow:var(--shadow);}
    .hero-inner{display:grid; grid-template-columns:1.25fr .75fr; gap:28px; padding:40px;}
    .badge{display:inline-flex; gap:10px; align-items:center; background:rgba(125,211,252,.08); border:1px solid rgba(125,211,252,.25); padding:8px 12px; border-radius:999px; font-weight:600; letter-spacing:.2px;}
    .title{font-size:clamp(28px, 4vw, 40px); line-height:1.15; margin:14px 0 8px; font-weight:800;}
    .subtitle{color:var(--muted); max-width:55ch}
    .hero-actions{display:flex; flex-wrap:wrap; gap:12px; margin-top:18px}
    .btn{display:inline-flex; align-items:center; gap:10px; border:1px solid rgba(255,255,255,.1); padding:12px 16px; border-radius:12px; background:linear-gradient(180deg, rgba(255,255,255,.04), rgba(255,255,255,.02)); color:var(--text); cursor:pointer; font-weight:600}
    .btn.primary{background:linear-gradient(180deg, var(--brand), #3b82f6); border:0; color:white; box-shadow:0 8px 24px rgba(37,99,235,.35)}
    .btn.ghost{background:transparent}

    /* Top navigation */
    .topnav{position:sticky; top:0; z-index:50; backdrop-filter:saturate(120%) blur(10px); background:color-mix(in oklab, var(--bg) 75%, transparent); border-bottom:1px solid color-mix(in oklab, var(--text) 8%, transparent)}
    .nav-inner{max-width:var(--maxw); margin:0 auto; display:flex; gap:20px; align-items:center; padding:10px 24px}
    .nav-links{display:flex; gap:16px; flex-wrap:wrap}
    .nav-links a{padding:8px 10px; border-radius:10px}
    .nav-links a:hover{background:color-mix(in oklab, var(--panel) 80%, transparent)}
    .spacer{flex:1}
    .search{position:relative}
    .search input{background:var(--panel); color:var(--text); border:1px solid rgba(255,255,255,.08); border-radius:12px; padding:10px 38px 10px 14px; box-shadow:var(--shadow); min-width:260px}
    .search .icon{position:absolute; right:10px; top:50%; transform:translateY(-50%); opacity:.6}

    /* Main grid */
    main{margin-top:22px}
    .grid{display:grid; grid-template-columns: 280px 1fr; gap:24px}
    @media (max-width: 980px){ .grid{grid-template-columns:1fr} }

    /* Sidebar */
    .sidebar{position:sticky; top:60px; height:max-content; padding:18px; background:var(--panel); border-radius:var(--radius-lg); box-shadow:var(--shadow);}
    .toc{display:flex; flex-direction:column; gap:4px}
    .toc a{padding:8px 10px; border-radius:10px; color:var(--muted)}
    .toc a:hover{background:color-mix(in oklab, var(--panel-2) 85%, transparent); color:var(--text)}

    /* Sections */
    section{scroll-margin-top:90px}
    .card{background:var(--panel); border-radius:var(--radius-lg); padding:22px; box-shadow:var(--shadow)}
    .h{display:flex; align-items:center; gap:10px; font-size:18px; font-weight:800; letter-spacing:.2px; margin:0 0 12px}
    .muted{color:var(--muted)}
    .chip{display:inline-flex; align-items:center; gap:8px; padding:6px 10px; border-radius:999px; border:1px solid rgba(255,255,255,.08); background:linear-gradient(180deg, rgba(255,255,255,.04), rgba(255,255,255,.02)); font-weight:600; font-size:12px; margin:4px 6px 0 0}

    /* Two column cards */
    .cols{display:grid; grid-template-columns:1fr 1fr; gap:16px}
    @media (max-width: 900px){ .cols{grid-template-columns:1fr} }
    .list{margin:8px 0 0 0; padding-left:18px}
    .list li{margin:6px 0}

    /* Algorithm stepper */
    .steps{display:grid; gap:14px;}
    .step{position:relative; padding:18px 18px 18px 54px; background:linear-gradient(180deg, var(--panel), color-mix(in oklab, var(--panel) 80%, var(--panel-2))); border:1px solid rgba(255,255,255,.06); border-radius:14px}
    .step .num{position:absolute; left:14px; top:14px; width:28px; height:28px; border-radius:8px; display:grid; place-items:center; font-weight:800; background:linear-gradient(180deg, var(--brand), #3b82f6); color:white; box-shadow:0 4px 14px rgba(37,99,235,.35)}
    .sub{margin:.25rem 0 0 0}

    /* Accordion */
    details{border:1px solid rgba(255,255,255,.08); border-radius:12px; padding:14px 16px; background:linear-gradient(180deg, var(--panel), rgba(255,255,255,.02));}
    details[open]{background:linear-gradient(180deg, var(--panel), rgba(255,255,255,.04));}
    details summary{cursor:pointer; font-weight:700}
    details .content{margin-top:10px}

    /* Callouts */
    .callout{display:flex; gap:14px; align-items:flex-start; padding:12px 14px; border-radius:12px; background:color-mix(in oklab, var(--brand) 12%, var(--panel)); border:1px dashed color-mix(in oklab, var(--brand) 30%, transparent)}
    .callout.warn{background:color-mix(in oklab, var(--warn) 10%, var(--panel)); border-color: color-mix(in oklab, var(--warn) 35%, transparent)}

    /* Footer */
    footer{opacity:.8; font-size:13px; margin:26px 0 40px}

    /* Print */
    @media print{
      :root{ --bg:#ffffff; --panel:#ffffff; --panel-2:#ffffff; --text:#000; --muted:#333; --brand:#000 }
      .topnav, .hero-actions, .sidebar{display:none !important}
      .container{max-width:100%; padding:0}
      .grid{grid-template-columns:1fr}
      header.hero{break-inside:avoid; box-shadow:none; border:0}
      .card{box-shadow:none; border:1px solid #ddd}
      a[href]::after{content:" (" attr(href) ")"; font-weight:normal; font-size:10px}
      section{page-break-inside:avoid}
    }
  </style>
</head>
<body>

  <!-- Sticky top navigation -->
  <nav class="topnav" aria-label="Quick nav">
    <div class="nav-inner">
      <strong>Hyperhidrosis Quick Reference</strong>
      <div class="nav-links">
        <a href="#definition">Definition</a>
        <a href="#classification">Classification</a>
        <a href="#assessment">Assessment</a>
        <a href="#diagnosis">Diagnostic Criteria</a>
        <a href="#management">Management</a>
        <a href="#specialist">Specialist Options</a>
        <a href="#key-takeaways">Key Takeaways</a>
      </div>
      <div class="spacer"></div>
      <div class="search" role="search">
        <input id="filter" type="search" placeholder="Quick filter (e.g. iontophoresis, HDSS)" />
        <svg class="icon" width="18" height="18" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true"><path d="M21 21l-4.3-4.3M10.5 18a7.5 7.5 0 1 1 0-15 7.5 7.5 0 0 1 0 15Z" stroke="currentColor" stroke-width="1.8" stroke-linecap="round"/></svg>
      </div>
    </div>
  </nav>

  <div class="container">
    <!-- Hero -->
    <header class="hero" role="banner">
      <div class="hero-inner">
        <div>
          <div class="badge" title="Updated Sept 2023">
            <svg width="18" height="18" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true"><path d="M12 2l2.39 4.84 5.34.78-3.86 3.76.91 5.32L12 14.9 6.22 16.7l.91-5.32L3.27 7.62l5.34-.78L12 2Z" stroke="currentColor" stroke-width="1.4"/></svg>
            NICE CKS (Sept 2023) + Clinic Pearls
          </div>
          <h1 class="title">Hyperhidrosis — One‑Page Clinical Algorithm & Quick Reference</h1>
          <p class="subtitle">Fast decision support for primary care consultations. Combines NICE CKS guidance with additional high‑yield practice points.</p>
          <div class="hero-actions">
            <button class="btn primary" onclick="window.print()" title="Print this page">
              <svg width="18" height="18" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true"><path d="M6 9V4h12v5M6 18H4a2 2 0 0 1-2-2v-4a3 3 0 0 1 3-3h14a3 3 0 0 1 3 3v4a2 2 0 0 1-2 2h-2M6 14h12v6H6v-6Z" stroke="white" stroke-width="1.6"/></svg>
              Print / Save PDF
            </button>
            <a class="btn ghost" href="#key-takeaways">
              <svg width="18" height="18" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M12 4v16m8-8H4" stroke="currentColor" stroke-width="1.8" stroke-linecap="round"/></svg>
              Jump to Summary
            </a>
          </div>
        </div>
        <div class="card">
          <h3 class="h">Hyperhidrosis Disease Severity Scale (HDSS)</h3>
          <ol class="list">
            <li><strong>1</strong> — Sweating not noticeable; doesn’t interfere with daily activities.</li>
            <li><strong>2</strong> — Tolerable; sometimes interferes.</li>
            <li><strong>3</strong> — Barely tolerable; frequently interferes.</li>
            <li><strong>4</strong> — Intolerable; always interferes.</li>
          </ol>
          <p class="muted">Interpretation: 1–2 = mild–moderate; 3–4 = moderate–severe.</p>
          <div class="callout warn" style="margin-top:10px">
            <svg width="20" height="20" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true"><path d="M12 9v4m0 4h.01M10.29 3.86 1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0Z" stroke="currentColor" stroke-width="1.6"/></svg>
            <div><strong>Night sweats</strong> → think infection (e.g., TB) or malignancy (e.g., Hodgkin’s). Always exclude serious causes in <em>generalized</em> sweating.</div>
          </div>
        </div>
      </div>
    </header>

    <main>
      <div class="grid">
        <!-- Sidebar TOC -->
        <aside class="sidebar" aria-label="On this page">
          <strong style="display:block; margin-bottom:8px">On this page</strong>
          <nav class="toc">
            <a href="#definition">Definition & Impact</a>
            <a href="#classification">Classification</a>
            <a href="#assessment">Assessment & Investigations</a>
            <a href="#diagnosis">Diagnostic Criteria</a>
            <a href="#algorithm">Algorithm</a>
            <a href="#management">Primary Care Management</a>
            <a href="#specialist">Specialist Options</a>
            <a href="#followup">Follow‑up</a>
            <a href="#key-takeaways">Key Takeaways</a>
          </nav>
        </aside>

        <!-- Content -->
        <div class="content">
          <section id="definition" class="card" aria-labelledby="h-def">
            <h2 id="h-def" class="h">Definition & Impact</h2>
            <ul class="list">
              <li><strong>Hyperhidrosis</strong> = chronic condition due to overactive eccrine sweat glands.</li>
              <li>True prevalence unknown (often under‑reported/under‑diagnosed).</li>
              <li>Significant impact on <em>quality of life</em>, relationships, school/work performance; risk of skin complications and psychosocial distress.</li>
            </ul>
            <div class="chips">
              <span class="chip">Primary care focus</span>
              <span class="chip">From age ≥12</span>
              <span class="chip">Consider QOL impact</span>
            </div>
          </section>

          <section id="classification" class="card" aria-labelledby="h-class">
            <h2 id="h-class" class="h">Classification</h2>
            <div class="cols">
              <article>
                <h3 class="h" style="font-size:16px">By distribution</h3>
                <ul class="list">
                  <li><strong>Localized (focal)</strong>: scalp/face, axillae, palms, soles.</li>
                  <li><strong>Generalized</strong>: whole body; <em>usually secondary</em>.</li>
                </ul>
              </article>
              <article>
                <h3 class="h" style="font-size:16px">By cause</h3>
                <ul class="list">
                  <li><strong>Primary hyperhidrosis</strong>: onset childhood/teens; family history in <em>30–50%</em>; sympathetic overactivity; stops during sleep; may improve with age.</li>
                  <li><strong>Secondary hyperhidrosis</strong>:
                    <ul class="list">
                      <li><em>Localized</em>: anxiety; stroke/brain or peripheral nerve lesions; gustatory sweating.</li>
                      <li><em>Generalized</em>: obesity; diabetes (incl. hypoglycaemia episodes); menopause; infections (TB, HIV, malaria); cancers (Hodgkin’s/lymphoma, carcinoid); endocrine (thyroid, phaeochromocytoma); cardiovascular/respiratory disease; Parkinson’s; <strong>drugs</strong> (antidepressants incl. SSRIs/SNRIs/TCAs, trazodone, mirtazapine; cholinesterase inhibitors; steroids; opioids; propranolol; others) and alcohol/illicit drugs or withdrawal.</li>
                    </ul>
                  </li>
                </ul>
              </article>
            </div>
          </section>

          <section id="assessment" class="card" aria-labelledby="h-assess">
            <h2 id="h-assess" class="h">Assessment & Investigations</h2>
            <div class="cols">
              <article>
                <h3 class="h" style="font-size:16px">History</h3>
                <ul class="list">
                  <li>Distribution, symmetry, frequency, duration (>6 months?), triggers (heat, stress, caffeine, alcohol, spicy foods), sleep‑onset.</li>
                  <li>Onset age; psychosocial impact; comorbidities; drug/alcohol history; family history.</li>
                  <li>Systemic symptoms (fever, weight loss, palpitations).</li>
                </ul>
                <p class="muted">Score severity with the <strong>HDSS</strong>.</p>
              </article>
              <article>
                <h3 class="h" style="font-size:16px">Exam & Tests</h3>
                <ul class="list">
                  <li>Examine distribution; BMI; complications (intertrigo, maceration, infections).</li>
                  <li><strong>Baseline labs</strong> (if secondary cause suspected or non‑specific features): FBC, ESR/CRP, U&Es, LFTs, HbA1c, TFTs.</li>
                  <li><strong>Chest X‑ray</strong> — key practice point.</li>
                  <li>As indicated: HIV/TB tests; blood film (malaria risk); 24h urine catecholamines/metanephrines ± 5‑HIAA; consider CXR already noted.</li>
                </ul>
                <div class="callout">
                  <svg width="20" height="20" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true"><path d="M4 12h16M4 6h16M4 18h16" stroke="currentColor" stroke-width="1.6"/></svg>
                  <div><strong>Generalized hyperhidrosis</strong> is usually <em>secondary</em> — actively exclude serious causes before symptom‑only treatment.</div>
                </div>
              </article>
            </div>
          </section>

          <section id="diagnosis" class="card" aria-labelledby="h-dx">
            <h2 id="h-dx" class="h">Diagnostic Criteria — Primary Focal Hyperhidrosis</h2>
            <ul class="list">
              <li>Focal, visible, excessive sweating in ≥1 site (axillae, palms, soles, craniofacial) <em>and</em> duration ≥6 months, no apparent cause, <em>and</em> ≥2 of:
                <ul class="list">
                  <li>Bilateral & relatively symmetrical</li>
                  <li>Interferes with ADLs</li>
                  <li>≥1 episode/week</li>
                  <li>Onset < 25 years</li>
                  <li>Positive family history</li>
                  <li>Stops during sleep</li>
                </ul>
              </li>
            </ul>
            <p class="muted">If duration <6 months or onset ≥25 yrs, primary disease is still possible — use clinical judgement to exclude secondary causes.</p>
          </section>

          <section id="algorithm" class="card" aria-labelledby="h-algo">
            <h2 id="h-algo" class="h">One‑Page Management Algorithm</h2>
            <div class="steps" id="algo-steps">
              <div class="step">
                <div class="num" aria-hidden="true">1</div>
                <strong>Assess & Triage</strong>
                <p class="sub">History, exam, HDSS. Identify focal vs generalized. Red flags: night sweats, weight loss, fever, systemic signs.</p>
              </div>
              <div class="step">
                <div class="num" aria-hidden="true">2</div>
                <strong>Investigate if secondary suspected</strong>
                <p class="sub">Baseline labs (FBC, ESR/CRP, U&Es, LFTs, HbA1c, TFTs), <u>Chest X‑ray</u>; targeted tests (HIV/TB, malaria film; 24h catecholamines/metanephrines ± 5‑HIAA) as indicated.</p>
              </div>
              <div class="step">
                <div class="num" aria-hidden="true">3</div>
                <strong>Primary focal hyperhidrosis diagnosed</strong>
                <p class="sub">Proceed to lifestyle + topical therapy; manage comorbid anxiety/depression; review at <strong>6 weeks</strong>.</p>
              </div>
              <div class="step">
                <div class="num" aria-hidden="true">4</div>
                <strong>First‑line (All focal sites): Aluminium chloride 20%</strong>
                <p class="sub">Apply nightly to <em>dry</em> skin → wash off AM; taper to PRN (up to q6w). Manage irritation with emollient/reduced frequency ± 1% hydrocortisone (short course).</p>
              </div>
              <div class="step">
                <div class="num" aria-hidden="true">5</div>
                <strong>Insufficient response after 6 weeks?</strong>
                <p class="sub">Consider <em>off‑label</em> oral antimuscarinic in primary care (e.g., <strong>oxybutynin</strong> 2.5 mg OD → titrate to 5 mg BD if tolerated; check local guidance) or refer to Dermatology.</p>
              </div>
              <div class="step">
                <div class="num" aria-hidden="true">6</div>
                <strong>Specialist escalation</strong>
                <p class="sub">Topical glycopyrrolate (craniofacial, off‑label), higher‑strength aluminium salts, oral glycopyrronium/oxybutynin (off‑label), propantheline (licensed for generalized), iontophoresis (palms/soles), botulinum toxin A (axilla licensed), surgery (select cases).</p>
              </div>
              <div class="step">
                <div class="num" aria-hidden="true">7</div>
                <strong>Long‑term plan</strong>
                <p class="sub">Maintenance (e.g., iontophoresis every 1–4 wks; repeat Botox q6–9 mo). Reassess triggers; revisit secondary causes if phenotype changes.</p>
              </div>
            </div>
          </section>

          <section id="management" class="card" aria-labelledby="h-mgmt">
            <h2 id="h-mgmt" class="h">Primary Care Management</h2>
            <div class="cols">
              <article>
                <h3 class="h" style="font-size:16px">Lifestyle / Self‑care</h3>
                <ul class="list">
                  <li>Loose, natural‑fibre clothing; avoid tight man‑made fabrics.</li>
                  <li>Triggers: heat, stress/anxiety, caffeine, alcohol, spicy foods.</li>
                  <li>Axillae: antiperspirants (not deodorants), underarm pads; prefer white/black clothing to mask marks.</li>
                  <li>Feet: moisture‑wicking socks; change ≥2×/day; absorbent powder; leather/open shoes; alternate pairs daily.</li>
                  <li>Resources: International Hyperhidrosis Society; BAD leaflet; NHS information page.</li>
                </ul>
              </article>
              <article>
                <h3 class="h" style="font-size:16px">Topical Aluminium Chloride (20%)</h3>
                <ul class="list">
                  <li>Nightly to dry skin (avoid after shaving/depilatories; avoid eyes/mucosa/broken skin); wash off in AM.</li>
                  <li>Then PRN maintenance (as infrequent as every 6 weeks once controlled).</li>
                  <li><em>Up to ~80% effective</em> in mild–moderate cases.</li>
                  <li>Irritation: reduce frequency, add emollients; short course <strong>hydrocortisone 1%</strong> up to 2 weeks if needed.</li>
                </ul>
              </article>
            </div>
            <details style="margin-top:12px">
              <summary>Oral therapy in primary care (off‑label) — consider with local guidance</summary>
              <div class="content">
                <ul class="list">
                  <li><strong>Oxybutynin</strong>: start 2.5 mg once daily → titrate to 5 mg twice daily as tolerated. Counsel on anticholinergic AEs (dry mouth, blurred vision, constipation, urinary retention). Modified‑release may improve tolerability.</li>
                  <li>Review efficacy and side‑effects within 4–6 weeks; stop if ineffective or poorly tolerated.</li>
                </ul>
              </div>
            </details>
          </section>

          <section id="specialist" class="card" aria-labelledby="h-spec">
            <h2 id="h-spec" class="h">Specialist Options (Dermatology)</h2>
            <details open>
              <summary><strong>Iontophoresis</strong> — palms/soles best evidence</summary>
              <div class="content">
                <ul class="list">
                  <li>Immersion or wet‑pad electrode with weak current; may add glycopyrronium to water if needed.</li>
                  <li>Maintenance every 1–4 weeks; recurrence common after stopping.</li>
                  <li>AEs: transient discomfort, erythema, vesicles.</li>
                </ul>
              </div>
            </details>
            <details>
              <summary><strong>Botulinum toxin A</strong> — axillae licensed; other sites off‑label</summary>
              <div class="content">
                <ul class="list">
                  <li>Multiple intradermal injections; effect ~6–9 months.</li>
                  <li>AEs: injection pain, compensatory sweating; transient weakness/fine motor issues (palms).</li>
                </ul>
              </div>
            </details>
            <details>
              <summary><strong>Topical/Oral agents</strong></summary>
              <div class="content">
                <ul class="list">
                  <li>Higher‑strength aluminium salts; topical glycopyrrolate (craniofacial, off‑label).</li>
                  <li>Oral antimuscarinics: oxybutynin, glycopyrronium (both off‑label for focal). <strong>Propantheline</strong> is licensed for <em>generalized</em> hyperhidrosis.</li>
                </ul>
              </div>
            </details>
            <details>
              <summary><strong>Surgery</strong> — last resort</summary>
              <div class="content">
                <ul class="list">
                  <li>Localized axillary sweat gland resection/laser for small areas.</li>
                  <li><strong>Endoscopic thoracic sympathectomy (ETS)</strong> for severe palmar/axillary/craniofacial cases refractory to all else.</li>
                  <li>Common complication: <em>compensatory hyperhidrosis</em> (e.g., back/legs), often 6–12 months post‑op; others: gustatory sweating, pneumothorax, atelectasis, bleeding.</li>
                </ul>
              </div>
            </details>
          </section>

          <section id="followup" class="card" aria-labelledby="h-fu">
            <h2 id="h-fu" class="h">Follow‑up</h2>
            <ul class="list">
              <li>Review at <strong>6 weeks</strong> after starting aluminium chloride; continue long‑term if effective.</li>
              <li>Address anxiety/depression where present; note some psych meds can worsen sweating.</li>
              <li>Reassess phenotype; if atypical/systemic signs emerge, re‑investigate for secondary causes.</li>
            </ul>
          </section>

          <section id="key-takeaways" class="card" aria-labelledby="h-kt">
            <h2 id="h-kt" class="h">Key Takeaways</h2>
            <ul class="list">
              <li><strong>Generalized</strong> hyperhidrosis is usually <em>secondary</em> → exclude serious causes first.</li>
              <li>Assessment includes <strong>CXR</strong> + baseline bloods where secondary suspected.</li>
              <li><strong>First‑line</strong>: lifestyle optimisation + 6‑week trial of 20% aluminium chloride.</li>
              <li>If unsuccessful: consider <em>off‑label</em> <strong>oxybutynin</strong> in primary care (per local guidance) or refer to dermatology.</li>
              <li>Multiple options exist (iontophoresis, Botox, surgery) — set expectations re. maintenance and recurrence.</li>
              <li>Prognosis: craniofacial/axillary often improve with age; palmar may persist/worsen at puberty.</li>
            </ul>
          </section>

          <footer>
            <p>Source: NICE Clinical Knowledge Summaries — Hyperhidrosis (last revised Sept 2023) combined with additional practice points. Medication uses marked <em>off‑label</em> require clinical judgement and local policy adherence.</p>
          </footer>
        </div>
      </div>
    </main>
  </div>

  <script>
    // Simple client-side filter to highlight matching text
    const filterInput = document.getElementById('filter');
    const contentRoot = document.querySelector('.content');
    let marks = [];

    function clearMarks(){
      marks.forEach(m=>{
        const parent = m.parentNode; if(parent){ parent.replaceChild(document.createTextNode(m.textContent), m);} });
      marks = [];
    }
    function markMatches(q){
      if(!q) return;
      const rx = new RegExp(q.replace(/[.*+?^${}()|[\]\\]/g,'\\$&'),'ig');
      const walker = document.createTreeWalker(contentRoot, NodeFilter.SHOW_TEXT, {
        acceptNode: node => node.nodeValue.trim().length>2 ? NodeFilter.FILTER_ACCEPT : NodeFilter.FILTER_REJECT
      });
      while(walker.nextNode()){
        const node = walker.currentNode;
        const text = node.nodeValue;
        if(rx.test(text)){
          const span = document.createElement('span');
          span.innerHTML = text.replace(rx, m=>`<mark style="background:color-mix(in oklab, var(--brand) 35%, transparent); padding:0 2px; border-radius:4px">${m}</mark>`);
          node.parentNode.replaceChild(span, node);
          span.querySelectorAll('mark').forEach(m=>marks.push(m));
        }
      }
    }
    filterInput?.addEventListener('input', (e)=>{ clearMarks(); const q=e.target.value.trim(); if(q) markMatches(q); });
  </script>
</body>
</html>